Search results
6 lis 2014 · Tests or procedures that cost less than $100,000 per year added are considered cost effective. In the NEJM analysis, researchers identified two groups for whom screening is the most cost-effective: current smokers and people ages 60-74.
13 maj 2022 · Most economic evaluations deemed screening for lung cancer with low dose computed tomography to be cost-effective. Screening should target those 55–75 with ≥20 pack-year smoking history, biennially and include smoking cessation interventions.
We assess the cost-effectiveness of a screening program that assesses indeterminate findings earlier via a hypothetical diagnostic biomarker introduced in place of Lung-RADS 3 and 4A guidelines.
24 kwi 2024 · Lung cancer screenings aren’t just for those with no history of lung cancer. They’re also a critical monitoring tool during lung cancer treatment and remission. Several members of MyLungCancerTeam have shared their struggles with getting insurance to cover the cost of ongoing scans.
8 sty 2022 · Main outcomes were costs, quality-adjusted life-years (QALYs), life expectancy life-years (LYs), incremental cost-effectiveness ratios (ICERs), and deaths from lung cancer. The willingness-to-pay level was US$100,000 per QALY gained.
15 kwi 2021 · In a study by Black et al (3), the estimated cost of screening based on the NLST results was $81 000 per quality-adjusted life year (QALY) gained. Most experts consider $100 000 per QALY gained as the threshold below which screening is considered an appropriate use of health care resources.
21 paź 2021 · Most economic evaluations deemed screening for lung cancer with low dose computed tomography to be cost-effective. Screening should target those 55–75 with ≥20 pack-year smoking history, biennially and include smoking cessation interventions.
